EUVIMEDEUVIMED entdecken
Crossref

Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry

Divya Chauhan, Tarun Shivach, Anurag S Rathore iD

Journal of the American Society for Mass Spectrometry · 2026

DOI: 10.1021/jasms.6c00136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2026. Verfasst von Divya Chauhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Indian Institute of Technology, Hauz Khas, New Delhi, Delhi110016, India. Hauptthemen laut MEDLINE: Polysaccharides, Immunoglobulin Fab Fragments, Immunoglobulin Fc Fragments, Cetuximab. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycosylation of monoclonal antibodies is a key determinant of their efficacy, stability, and safety, requiring analytical methods capable of resolving site-specific heterogeneity with high sensitivity. In this work, we present a Protein A-assisted, domain-resolved glycan profiling approach for the mass spectrometry-based structural elucidation and quantification of N-glycans linked to Fc and Fab in cetuximab. Antibody domains were selectively extracted using Protein A affinity separation, allowing for independent enzymatic release of N-glycans from Fc and Fab sections, followed by high-resolution mass spectrometry for detailed glycan profiling and comparative characterization of Fc- and Fab-associated glycan populations. In comparison to conventional total glycan analysis, our technique decreases spectral complexity and allows for obvious distinction of domain-specific glycosylation patterns. Crucially, domain-specific released glycan profiling improves the detection and precise measurement of low-abundance glycoforms, such as sialylated, high-mannose, and afucosylated species that frequently remain hidden in conventional approaches. The proposed approach facilitates domain-specific characterization of glycan distributions across antibody regions by reducing analytical complexity and improving interpretation of Fc- and Fab-associated glycosylation patterns. Our results show that a reliable and repeatable platform for thorough, domain-level glycan characterization and quantification is available, supporting applications in quality control and biosimilar comparability studies, and in general during biopharmaceutical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsCetuximabMass SpectrometryGlycosylationHumans

Stichwörter der Autor:innen

N-glycosylationFc/fab glycanscetuximabdomain-resolved glycan profilingmass spectrometryprotein A affinity

Substanzen

PolysaccharidesImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsCetuximab

Autor:innen und Institutionen

  • Department of Chemical Engineering, Indian Institute of Technology, Hauz Khas, New Delhi, Delhi110016, India.

ORCID-Profile: Anurag S Rathore

Zitieren

APA

Chauhan, D., Shivach, T., & Rathore, A. S. (2026). Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.6c00136

Vancouver

Chauhan D, Shivach T, Rathore AS. Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.6c00136

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Divya and Shivach, Tarun and Rathore, Anurag S},
  title = {Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  doi = {10.1021/jasms.6c00136}
}
Kostenlos starten →